Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Sep 17, 2009

Premium

Regulus Therapeutics, the microRNA drugs joint venture of Alnylam Pharmaceuticals and Isis Pharmaceuticals, has named Hubert Chen as its vice president of translational medicine.

In the role, Chen will be "responsible for leading the translation of the important biological discoveries in the field of microRNA therapeutics into new medicines," Regulus said.

Before joining Regulus, Chen was senior director of clinical research at Amylin Pharmaceuticals. Before that, he was associate director of medical sciences at Amgen.

He holds an MD from Columbia University and a BAS in political sciences and biological sciences from Stanford University.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.